Tolerogenic Vaccination with MOG/VitD Overcomes Aggravating Effect of C. albicans in Experimental Encephalomyelitis

Thais F C Fraga-Silva1, Luiza A N Mimura1, Sofia F G Zorzella-Pezavento1

  • 1Department of Microbiology and Immunology, Institute of Biosciences of Botucatu, Univ. Estadual Paulista (UNESP), Botucatu, São Paulo, Brazil.

Abstract

Insights

This study shows that vaccination with myelin peptide and vitamin D effectively prevents experimental autoimmune encephalomyelitis (EAE), a model for multiple sclerosis, even when mice are infected with Candida albicans.

Area of Science:

  • Neuroimmunology
  • Infectious Disease Immunology

Background:

  • Multiple sclerosis (MS) is a CNS demyelinating disorder.
  • Candida albicans (Ca) infection exacerbates experimental autoimmune encephalomyelitis (EAE), an MS model.
  • Vaccination with myelin peptide (MOG) and vitamin D (VitD) previously showed protective effects against EAE.

Purpose of the Study:

  • To investigate if Ca infection impacts the efficacy of MOG+VitD vaccination against EAE.
  • To determine the immunoregulatory mechanisms underlying protection.

Main Methods:

  • EAE was induced in C57BL/6 female mice vaccinated with MOG+VitD.
  • Mice were infected with Ca three days before EAE induction.
  • Immune cell analysis and cytokine production were assessed.

Main Results:

  • MOG+VitD vaccination controlled EAE in Ca-infected mice, with minimal clinical scores and weight loss.
  • Reduced CNS inflammation and lower production of encephalitogenic cytokines were observed.
  • Increased CD25(+) FoxP3(+) regulatory T cells and successful adoptive transfer of splenocytes indicated immune regulation.

Conclusions:

  • MOG+VitD vaccination is effective in preventing EAE, even with concurrent Ca infection.
  • The protective effect is mediated by immunoregulatory cells, likely involving regulatory T cells.